|
| 37880516 | Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6. | Ann Surg Oncol | 2024 |
| 37796181 | Neutrophil Elastase Remodels Mammary Tumors to Facilitate Lung Metastasis. | Mol Cancer Ther | 2024 |
| 37880516 | Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6. | Ann Surg Oncol | 2024 |
| 38062294 | Surgical Oncology Heroes and Legends: Charles M. Balch, MD, as Interviewed by Kelly K. Hunt, MD. | Ann Surg Oncol | 2024 |
| 37478956 | American Radium Society Appropriate Use Criteria Postmastectomy Radiation Therapy: Executive Summary of Clinical Topics. | Int J Radiat Oncol Biol Phys | 2024 |
| 37796181 | Neutrophil Elastase Remodels Mammary Tumors to Facilitate Lung Metastasis. | Mol Cancer Ther | 2024 |
| 38062294 | Surgical Oncology Heroes and Legends: Charles M. Balch, MD, as Interviewed by Kelly K. Hunt, MD. | Ann Surg Oncol | 2024 |
| 37478956 | American Radium Society Appropriate Use Criteria Postmastectomy Radiation Therapy: Executive Summary of Clinical Topics. | Int J Radiat Oncol Biol Phys | 2024 |
| 33938495 | Prospective Study of Pain Outcomes Associated With Breast Surgery in Women With Nonhereditary Breast Cancer. | Ann Surg | 2023 |
| 36245056 | ASO Visual Abstract: Re-Excision After Unplanned Excision of Soft Tissue Sarcoma Is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease. | Ann Surg Oncol | 2023 |
| 36094691 | Other Primary Malignancies in Patients with Breast Cancer Who Undergo Germline Panel Testing. | Ann Surg Oncol | 2023 |
| 36161369 | ASO Visual Abstract: Clinical Impact of External Beam Radiotherapy for Surgically Resected Primary Retroperitoneal Liposarcoma. | Ann Surg Oncol | 2023 |
| 36085392 | Re-excision After Unplanned Excision of Soft Tissue Sarcoma is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease. | Ann Surg Oncol | 2023 |
| 36210399 | ASO Visual Abstract: Other Primary Malignancies in Patients with Breast Cancer Who Undergo Germline Panel Testing. | Ann Surg Oncol | 2023 |
| 36419172 | Response to: What Is Missing From the 2022 Practice Recommendation Updates From the World Consensus Conference on BIA-ALCL? | Aesthet Surg J | 2023 |
| 36394686 | ASO Author Reflections: A Call for Consensus, Collaboration and Data on the Role of Sentinel Lymph Node Biopsy for Soft Tissue Sarcoma. | Ann Surg Oncol | 2023 |
| 36115928 | Clinical Impact of External Beam Radiotherapy for Surgically Resected Primary Retroperitoneal Liposarcoma. | Ann Surg Oncol | 2023 |
| 37941561 | Longitudinal dynamic contrast-enhanced MRI radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer. | Front Oncol | 2023 |
| 37670121 | To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer? | Ann Surg Oncol | 2023 |
| 37835523 | Deep Learning for Fully Automatic Tumor Segmentation on Serially Acquired Dynamic Contrast-Enhanced MRI Images of Triple-Negative Breast Cancer. | Cancers (Basel) | 2023 |
| 37736254 | Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery. | Oncoscience | 2023 |
| 36653664 | Local-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast Cancer. | Ann Surg Oncol | 2023 |
| 36831368 | Assessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRI. | Cancers (Basel) | 2023 |
| 36826618 | ASO Visual Abstract: Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma (ETSTS): A Survey of the Society of Surgical Oncology (SSO) and Musculoskeletal Tumor Society (MSTS) Membership. | Ann Surg Oncol | 2023 |
| 36648270 | Setting the Standard for Cutaneous Melanoma Wide Local Excision: An Overview of the American College of Surgeons Commission on Cancer Standard 5.5. | J Am Coll Surg | 2023 |
| 37458948 | Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection. | Ann Surg Oncol | 2023 |
| 37202308 | Operative standards for sentinel lymph node biopsy and axillary lymphadenectomy for breast cancer: review of the American College of Surgeons commission on cancer standards 5.3 and 5.4. | Surgery | 2023 |
| 37384539 | Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor-Positive Metastatic Breast Cancers. | Cancer Res | 2023 |
| 36745260 | ASO Visual Abstract: Local-Regional Recurrence Following Neoadjuvant Endocrine Therapy - Data from ACOSOG Z1031 (Alliance), a Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2-3 Breast Cancer. | Ann Surg Oncol | 2023 |
| 36603130 | Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time. | Cancer Res | 2023 |
| 36670144 | Prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer using deep learning on multiparametric MRI. | Sci Rep | 2023 |
| 36977292 | Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance). | J Clin Oncol | 2023 |
| 36723723 | Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma: A Survey of the Society of Surgical Oncology and Musculoskeletal Tumor Society Membership. | Ann Surg Oncol | 2023 |
| 33938495 | Prospective Study of Pain Outcomes Associated With Breast Surgery in Women With Nonhereditary Breast Cancer. | Ann Surg | 2023 |
| 37670121 | To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer? | Ann Surg Oncol | 2023 |
| 37941561 | Longitudinal dynamic contrast-enhanced MRI radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer. | Front Oncol | 2023 |
| 37835523 | Deep Learning for Fully Automatic Tumor Segmentation on Serially Acquired Dynamic Contrast-Enhanced MRI Images of Triple-Negative Breast Cancer. | Cancers (Basel) | 2023 |
| 37736254 | Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery. | Oncoscience | 2023 |
| 37458948 | Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection. | Ann Surg Oncol | 2023 |
| 37384539 | Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor-Positive Metastatic Breast Cancers. | Cancer Res | 2023 |
| 36977292 | Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance). | J Clin Oncol | 2023 |
| 37202308 | Operative standards for sentinel lymph node biopsy and axillary lymphadenectomy for breast cancer: review of the American College of Surgeons commission on cancer standards 5.3 and 5.4. | Surgery | 2023 |
| 36723723 | Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma: A Survey of the Society of Surgical Oncology and Musculoskeletal Tumor Society Membership. | Ann Surg Oncol | 2023 |
| 36653664 | Local-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast Cancer. | Ann Surg Oncol | 2023 |
| 36648270 | Setting the Standard for Cutaneous Melanoma Wide Local Excision: An Overview of the American College of Surgeons Commission on Cancer Standard 5.5. | J Am Coll Surg | 2023 |
| 36745260 | ASO Visual Abstract: Local-Regional Recurrence Following Neoadjuvant Endocrine Therapy - Data from ACOSOG Z1031 (Alliance), a Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2-3 Breast Cancer. | Ann Surg Oncol | 2023 |
| 36831368 | Assessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRI. | Cancers (Basel) | 2023 |
| 36603130 | Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time. | Cancer Res | 2023 |
| 36826618 | ASO Visual Abstract: Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma (ETSTS): A Survey of the Society of Surgical Oncology (SSO) and Musculoskeletal Tumor Society (MSTS) Membership. | Ann Surg Oncol | 2023 |
| 36670144 | Prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer using deep learning on multiparametric MRI. | Sci Rep | 2023 |